About
ARase Therapeutics develops first-in-class oncology therapeutics targeting ADP-ribose hydrolases, which are enzymes involved in cancer signaling and stress response pathways.
Explore ARase Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.